Cochlear (ASX:COH) will continue to operate under a duty-free arrangement with the US as it awaits clarity on recent trade developments, the maker of hearing implants said in a Tuesday filing with the Australian bourse.
Cochlear is currently under the Harmonized Tariff Schedule of the US that provides duty-free importation on a range of products into the US, including hearing implants, per the filing.
The company said it will "continue to actively monitor and engage in the evolving global landscape" in line with the imposition of a 10% tariff on exports to the US from Australia.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。